Intermediate‐dose anticoagulation, aspirin, and in‐hospital mortality in COVID‐19: a propensity score‐matched analysis
…, G Goshua, Y Liu, R Fine, K Amin… - American journal of …, 2021 - Wiley Online Library
Thrombotic complications occur at high rates in hospitalized patients with COVID‐19, yet
the impact of intensive antithrombotic therapy on mortality is uncertain. We examined in‐…
the impact of intensive antithrombotic therapy on mortality is uncertain. We examined in‐…
A review of FLT3 inhibitors in acute myeloid leukemia
JC Zhao, S Agarwal, H Ahmad, K Amin, JP Bewersdorf… - Blood reviews, 2022 - Elsevier
FLT3 mutations are the most common genetic aberrations found in acute myeloid leukemia (AML)
and associated with poor prognosis. Since the discovery of FLT3 mutations and their …
and associated with poor prognosis. Since the discovery of FLT3 mutations and their …
[HTML][HTML] EPOCH is a safe and effective treatment option for aggressive T-cell lymphomas
T Sethi, R Gerstein, M Schiffer, K Amin, S Agarwal… - Blood, 2021 - Elsevier
Background: T-cell lymphomas constitute heterogeneous subtypes of non-Hodgkin lymphoma
(NHL). With the exception of brentuximab (BV) with cyclophosphamide, adriamycin, …
(NHL). With the exception of brentuximab (BV) with cyclophosphamide, adriamycin, …
[HTML][HTML] Admission Rothman index, aspirin, and intermediate dose anticoagulation effects on outcomes in COVID-19: a multi-site propensity matched analysis
G Goshua, Y Liu, ML Meizlish, R Fine, K Amin… - Blood, 2020 - Elsevier
Introduction: Venous thromboembolism and in-situ small vessel thrombosis are increased in
hospitalized patients with COVID-19 in several patient cohorts. Endotheliopathy and …
hospitalized patients with COVID-19 in several patient cohorts. Endotheliopathy and …
[HTML][HTML] Cardio-oncology: the intersection between cardiovascular disease and cancer
JS Coviello, K Amin - Journal of the Advanced Practitioner in …, 2021 - ncbi.nlm.nih.gov
Cardio-oncology is a rapidly emerging field, and advanced practitioners (APs) play key roles
in the prevention, early detection, and optimal treatment of cardiotoxicities associated with …
in the prevention, early detection, and optimal treatment of cardiotoxicities associated with …
BPI23-012: Real-World Frequency of ECHO Monitoring and Incidence of Anti-HER2 Therapy Related Cardiac Events in HER2+ Breast Cancer Patients
…, J Majeski, L Pusztai, K Adelson, K Amin - Journal of the National …, 2023 - jnccn.org
Background: Current guidelines recommend monitoring cardiac function every 3 months in
patients on anti-HER2 therapies, such as trastuzumab and pertuzumab. The purpose of this …
patients on anti-HER2 therapies, such as trastuzumab and pertuzumab. The purpose of this …
[PDF][PDF] Enhancing Antibiotic Stewardship Team (AST) Efforts in Decreasing Inappropriate Vancomycin Usage in Neutropenic Fever (NF) Patients through Unit Based …
S Perreault, K Amin, S Daleo… - Open Forum …, 2017 - pdfs.semanticscholar.org
Conclusion. PST led to immediate antimicrobial de-escalation in the majority of patients
who tested negative. Most of these patients were transitioned to optimal therapy or de-escalated …
who tested negative. Most of these patients were transitioned to optimal therapy or de-escalated …
Intermediate-dose anticoagulation, aspirin, and in-hospital mortality in COVID-19: a propensity score-matched analysis (preprint)
ML Meizlish, G Goshua, Y Liu, R Fine, K Amin… - 2021 - pesquisa.bvsalud.org
BackgroundThrombotic complications occur at high rates in hospitalized patients with
COVID-19, yet the impact of intensive antithrombotic therapy on mortality is uncertain. Research …
COVID-19, yet the impact of intensive antithrombotic therapy on mortality is uncertain. Research …
Single agent blinatumumab as frontline therapy for an 85-year-old patient with B cell precursor acute lymphoblastic leukemia
…, NA Podoltsev, T Prebet, L Barbarotta, K Amin… - Annals of …, 2016 - Springer
Dear Editor, The outcomes of older patients with acute lymphoblastic leukemia (ALL)
remain dismal and the therapeutic options are limited. We present the case of an 85-year-old …
remain dismal and the therapeutic options are limited. We present the case of an 85-year-old …
[PDF][PDF] 1572. Elimination of Aerosol Ribavirin Use in Immunocompromised Patients with Metapneumovirus and Parainfluenza Virus Infections
DSL Davis - pdfs.semanticscholar.org
Conclusion. PST led to immediate antimicrobial de-escalation in the majority of patients
who tested negative. Most of these patients were transitioned to optimal therapy or de-escalated …
who tested negative. Most of these patients were transitioned to optimal therapy or de-escalated …